The Female Health Company (NASDAQ:FHCO) is a specialty pharmaceutical and medical device company focused on pharmaceutical products that qualify for the 505(b)(2) FDA regulatory pathway that can result in more rapid approval than a full new drug application. Through its Global Public Health Division, the company manages the global public health sector FC2 Female Condom® (FC2) business, marketing FC2 to a variety of entities that aim to support and improve the well-being of women worldwide. Veru Healthcare manages the development and commercialization of pharmaceutical and medical device products for men’s and women’s health and oncology, as well as commercialization of sexual health products, including FC2 Female Condom® (FC2) and PREBOOST. For more information, visit the company’s website at www.femalehealth.com.
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.networknewswire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.net
